{"disease":{"id":"lupus-membranous-nephropathy","name":"lupus membranous nephropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05732402","title":"An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Alpine Immune Sciences, Inc.","has_results":false},{"nct_id":"NCT06285279","title":"The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Nanjing University School of Medicine","has_results":false},{"nct_id":"NCT03453619","title":"Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Apellis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03285711","title":"Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Gilead Sciences","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}